Literature DB >> 35928084

Simultaneous use of Tumor Necrosis Factor, Lipid Profile, and β-hCG As Markers of Severity of Preeclampsia.

Reham Elazab1, Mostafa Alkhiary2, Mohamed Bedairi2, Alaa Wageh2.   

Abstract

Objective: Tumor necrosis factor, Lipid Profile, and β-hCG are markers that proved to be changed with preeclampsia. We aim to study their combined use as predictors of the severity of preeclampsia.
Methods: A case-control study was conducted in our University Hospitals on pregnant women complicated by mild or severe PE and healthy normal pregnant women as a control group. Samples of these markers were taken at a gestational age between 28 and 36 weeks.
Results: A total number of 90 pregnant women were selected. The first group was mild PE (17 cases), the second group was severe PE (28 cases), and the third group was normal pregnant women (control group 45 cases). There is a statistically significant positive correlation between β-hCG, triglycerides, Cholesterol, LDL, VLDL, and Tumor necrosis factor. These markers correlate with the severity of PE. HDL demonstrates a statistically significant negative correlation with TNF-α and β-hCG. Conclusions: There is a strong correlation between the increase of TNF, β-hCG, triglycerides, LDL, and cholesterol in cases of PE. These markers are associated with the severity of PE. These markers can be incorporated into a predictive model for PE. © Federation of Obstetric & Gynecological Societies of India 2021.

Entities:  

Keywords:  Lipid profile; Preeclampsia; Tumor necrosis factor; β-hCG

Year:  2021        PMID: 35928084      PMCID: PMC9343506          DOI: 10.1007/s13224-021-01556-0

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  21 in total

1.  A prognostic model to guide decision-making on timing of delivery in late preterm pre-eclampsia: the PEACOCK prospective cohort study.

Authors:  Kate Duhig; Paul T Seed; Anna Placzek; Jenie Sparkes; Carolyn Gill; Anna Brockbank; Andrew Shennan; Shakila Thangaratinam; Lucy C Chappell
Journal:  Health Technol Assess       Date:  2021-05       Impact factor: 4.014

2.  The role of serum adipokine levels in preeclampsia: A systematic review.

Authors:  Georgios Daskalakis; Ioannis Bellos; Melina Nikolakea; Vasilios Pergialiotis; Angeliki Papapanagiotou; Dimitrios Loutradis
Journal:  Metabolism       Date:  2020-02-04       Impact factor: 8.694

3.  Association of MicroRNA-210 and MicroRNA-155 with severity of preeclampsia.

Authors:  Hanan Mohamed Gabr Youssef; Elham Sayed Marei
Journal:  Pregnancy Hypertens       Date:  2019-05-10       Impact factor: 2.899

4.  Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A meta-analysis including 3982 patients.

Authors:  Qingling Kang; Wei Li; Nan Yu; Lei Fan; Yang Zhang; Menghan Sha; Juan Xiao; Jianli Wu; Qingwen Kang; Suhua Chen
Journal:  Pregnancy Hypertens       Date:  2020-03-24       Impact factor: 2.899

5.  Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis.

Authors:  Cassandra N Spracklen; Caitlin J Smith; Audrey F Saftlas; Jennifer G Robinson; Kelli K Ryckman
Journal:  Am J Epidemiol       Date:  2014-07-02       Impact factor: 4.897

Review 6.  Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis.

Authors:  Sien Yee Lau; Sarah-Jane Guild; Carolyn J Barrett; Qi Chen; Leslie McCowan; Vanessa Jordan; Lawrence W Chamley
Journal:  Am J Reprod Immunol       Date:  2013-06-24       Impact factor: 3.886

7.  Concomitant intrauterine growth restriction alters the lipoprotein profile in preeclampsia.

Authors:  Christine Contini; B Sophia Winkler; Nicolai Maass; Ibrahim Alkatout; Karl Winkler; Ulrich Pecks
Journal:  Pregnancy Hypertens       Date:  2018-12-31       Impact factor: 2.899

8.  Association between serum beta-human chorionic gonadotropin and preeclampsia and its effects on perinatal and maternal outcomes: a case control study.

Authors:  Sayran Ibrahem Taher; Shahla Kareem Alalaf
Journal:  Arch Gynecol Obstet       Date:  2019-01-31       Impact factor: 2.344

Review 9.  Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review.

Authors:  U Vivian Ukah; Dane A De Silva; Beth Payne; Laura A Magee; Jennifer A Hutcheon; Helen Brown; J Mark Ansermino; Tang Lee; Peter von Dadelszen
Journal:  Pregnancy Hypertens       Date:  2017-11-21       Impact factor: 2.899

10.  The role of cytokines as inflammatory mediators in preeclampsia.

Authors:  Ifeoma Udenze; Casimir Amadi; Nicholas Awolola; Christian Chigozie Makwe
Journal:  Pan Afr Med J       Date:  2015-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.